| 2022 | | Quality of life outcomes from the randomized trial of hyperthermic intraperitoneal chemotherapy following cytoreductive surgery for primary ovarian cancer (KOV-HIPEC-01) | 장석준 |
| 2006 | | Rare case of stage IA epithelial ovarian cancer with bone as the first site of recurrent metastasis. | 유희석, 이정필, 장기홍 |
| 2020 | | Real world effectiveness and safety of pegylated liposomal doxorubicin in platinum-sensitive recurrent ovarian, fallopian, or primary peritoneal cancer: a Korean multicenter retrospective cohort study | 장석준 |
| 2019 | | Real-world effectiveness of bevacizumab based on AURELIA in platinum-resistant recurrent ovarian cancer (REBECA): A Korean Gynecologic Oncology Group study (KGOG 3041) | 장석준 |
| 2018 | | Risk factors for septic adverse events and their impact on survival in advanced ovarian cancer patients treated with neoadjuvant chemotherapy and interval debulking surgery | 공태욱, 백지흠, 손주혁, 유희석, 장석준 |
| 2023 | | Risk factors for the failure of first-line PARP inhibitor maintenance therapy in patients with advanced ovarian cancer: Gynecologic Oncology Research Investigators Collaboration Study (GORILLA-3004) | 공태욱, 김지연, 손주혁, 장석준 |
| 2016 | | Robotic single-site versus laparo-endoscopic single-site surgery for adnexal tumours: a propensity score-matching analysis | 공태욱, 백지흠, 유희석, 장석준 |
| 2015 | | Role of aggressive surgical cytoreduction in advanced ovarian cancer. | 장석준 |
| 2019 | | Selection of patients with ovarian cancer who may show survival benefit from hyperthermic intraperitoneal chemotherapy: A systematic review and meta-analysis | 장석준 |
| 2023 | | Significance of cholecystectomy in cytoreductive surgery for advanced ovarian cancer | 공태욱, 김지연, 손주혁, 장석준 |
| 2024 | | Surgery for Recurrent Epithelial Ovarian Cancer | 장석준 |
| 2016 | | Surgical management of recurrent ovarian cancer | 장석준 |
| 2017 | | Surgical manual of the Korean Gynecologic Oncology Group: ovarian, tubal, and peritoneal cancers | 장석준 |
| 2015 | | Surgical technique of en bloc pelvic resection for advanced ovarian cancer. | 장석준 |
| 2022 | | Survival After Hyperthermic Intraperitoneal Chemotherapy and Primary or Interval Cytoreductive Surgery in Ovarian Cancer: A Randomized Clinical Trial | 장석준 |
| 2013 | | Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: a meta-analysis. | 장석준 |
| 2022 | | The Clinical Desire for Pressurized Intraperitoneal Aerosol Chemotherapy in South Korea: An Electronic Survey-based Study | 장석준 |
| 2019 | | The impact of primary tumor location in patients with metastatic colorectal cancer: a Korean Cancer Study Group CO12-04 study | 강석윤 |
| 2011 | | The Korean Hereditary Breast Cancer (KOHBRA) study: protocols and interim report. | 김구상, 정용식 |
| 2010 | | The role of cytoreductive surgery for non-genital tract metastatic tumors to the ovaries. | 김우영 |
| 2016 | | Total parietal peritonectomy with en bloc pelvic resection for advanced ovarian cancer with peritoneal carcinomatosis | 장석준 |
| 2016 | | Transvaginal Sonography-Guided Core Biopsy of Adnexal Masses as a Useful Diagnostic Alternative Replacing Cytologic Examination or Laparoscopy in Advanced Ovarian Cancer Patients | 공태욱, 백지흠, 유희석, 이용희, 이은주, 장석준 |
| 2010 | | Young girls with malignant ovarian germ cell tumors can undergo normal menarche and menstruation after fertility-preserving surgery and adjuvant chemotherapy. | 김우영, 유승철, 유희석, 윤종혁, 장기홍, 장석준 |
